447 related articles for article (PubMed ID: 11950918)
1. Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas.
Kahn HJ; Bailey D; Marks A
Mod Pathol; 2002 Apr; 15(4):434-40. PubMed ID: 11950918
[TBL] [Abstract][Full Text] [Related]
2. Expression of D2-40 in lymphatic endothelium of normal tissues and in vascular tumours.
Fukunaga M
Histopathology; 2005 Apr; 46(4):396-402. PubMed ID: 15810951
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor receptor-3 (VEGFR-3): a marker of vascular tumors with presumed lymphatic differentiation, including Kaposi's sarcoma, kaposiform and Dabska-type hemangioendotheliomas, and a subset of angiosarcomas.
Folpe AL; Veikkola T; Valtola R; Weiss SW
Mod Pathol; 2000 Feb; 13(2):180-5. PubMed ID: 10697276
[TBL] [Abstract][Full Text] [Related]
4. Identification of lymphatic endothelium in pediatric vascular tumors and malformations.
Galambos C; Nodit L
Pediatr Dev Pathol; 2005; 8(2):181-9. PubMed ID: 15719202
[TBL] [Abstract][Full Text] [Related]
5. [Podoplanin--a specific marker for lymphatic endothelium expressed in angiosarcoma].
Breiteneder-Geleff S; Soleiman A; Horvat R; Amann G; Kowalski H; Kerjaschki D
Verh Dtsch Ges Pathol; 1999; 83():270-5. PubMed ID: 10714221
[TBL] [Abstract][Full Text] [Related]
6. Positive staining of tumor-stage Kaposi sarcoma with lymphatic marker D2-40.
Dubina M; Goldenberg G
J Am Acad Dermatol; 2009 Aug; 61(2):276-80. PubMed ID: 19615538
[TBL] [Abstract][Full Text] [Related]
7. Prox-1 and VEGFR3 antibodies are superior to D2-40 in identifying endothelial cells of lymphatic malformations--a proposal of a new immunohistochemical panel to differentiate lymphatic from other vascular malformations.
Castro EC; Galambos C
Pediatr Dev Pathol; 2009; 12(3):187-94. PubMed ID: 18937526
[TBL] [Abstract][Full Text] [Related]
8. Expression of a lymphatic endothelial cell marker in benign and malignant vascular tumors.
Xu H; Edwards JR; Espinosa O; Banerji S; Jackson DG; Athanasou NA
Hum Pathol; 2004 Jul; 35(7):857-61. PubMed ID: 15257549
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of D2-40 immunohistochemistry for differentiation between kaposiform hemangioendothelioma and tufted angioma.
Arai E; Kuramochi A; Tsuchida T; Tsuneyoshi M; Kage M; Fukunaga M; Ito T; Tada T; Izumi M; Shimizu K; Hirose T; Shimizu M
J Cutan Pathol; 2006 Jul; 33(7):492-7. PubMed ID: 16872472
[TBL] [Abstract][Full Text] [Related]
10. Endothelial cell markers CD31, CD34, and BNH9 antibody to H- and Y-antigens--evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor.
Miettinen M; Lindenmayer AE; Chaubal A
Mod Pathol; 1994 Jan; 7(1):82-90. PubMed ID: 7512718
[TBL] [Abstract][Full Text] [Related]
11. Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3.
Jussila L; Valtola R; Partanen TA; Salven P; Heikkilä P; Matikainen MT; Renkonen R; Kaipainen A; Detmar M; Tschachler E; Alitalo R; Alitalo K
Cancer Res; 1998 Apr; 58(8):1599-604. PubMed ID: 9563467
[TBL] [Abstract][Full Text] [Related]
12. Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors.
Partanen TA; Alitalo K; Miettinen M
Cancer; 1999 Dec; 86(11):2406-12. PubMed ID: 10590384
[TBL] [Abstract][Full Text] [Related]
13. Co-expression of endothelial cell and macrophage antigens in Kaposi's sarcoma cells.
Uccini S; Ruco LP; Monardo F; Stoppacciaro A; Dejana E; La Parola IL; Cerimele D; Baroni CD
J Pathol; 1994 May; 173(1):23-31. PubMed ID: 7523640
[TBL] [Abstract][Full Text] [Related]
14. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium.
Breiteneder-Geleff S; Soleiman A; Kowalski H; Horvat R; Amann G; Kriehuber E; Diem K; Weninger W; Tschachler E; Alitalo K; Kerjaschki D
Am J Pathol; 1999 Feb; 154(2):385-94. PubMed ID: 10027397
[TBL] [Abstract][Full Text] [Related]
15. Retiform hemangioendotheliomas usually do not express D2-40 and VEGFR-3.
Parsons A; Sheehan DJ; Sangueza OP
Am J Dermatopathol; 2008 Feb; 30(1):31-3. PubMed ID: 18212541
[TBL] [Abstract][Full Text] [Related]
16. Expression of PROX-1 in oral Kaposi's sarcoma spindle cells.
Benevenuto de Andrade BA; Ramírez-Amador V; Anaya-Saavedra G; Martínez-Mata G; Fonseca FP; Graner E; Paes de Almeida O
J Oral Pathol Med; 2014 Feb; 43(2):132-6. PubMed ID: 23763431
[TBL] [Abstract][Full Text] [Related]
17. Lymphatic differentiation in classic Kaposi's sarcoma: patterns of D2-40 immunoexpression in the course of tumor progression.
Kandemir NO; Barut F; Gun BD; Keser SH; Karadayi N; Gun M; Ozdamar SO
Pathol Oncol Res; 2011 Dec; 17(4):843-51. PubMed ID: 21479874
[TBL] [Abstract][Full Text] [Related]
18. Expression of vascular endothelial growth factor receptor-3 and podoplanin suggests a lymphatic endothelial cell origin of Kaposi's sarcoma tumor cells.
Weninger W; Partanen TA; Breiteneder-Geleff S; Mayer C; Kowalski H; Mildner M; Pammer J; Stürzl M; Kerjaschki D; Alitalo K; Tschachler E
Lab Invest; 1999 Feb; 79(2):243-51. PubMed ID: 10068212
[TBL] [Abstract][Full Text] [Related]
19. Induction of vascular endothelial growth factor receptor-3 expression on tumor microvasculature as a new progression marker in human cutaneous melanoma.
Clarijs R; Schalkwijk L; Hofmann UB; Ruiter DJ; de Waal RM
Cancer Res; 2002 Dec; 62(23):7059-65. PubMed ID: 12460927
[TBL] [Abstract][Full Text] [Related]
20. AIDS-related Kaposi's sarcoma displays differential expression of endothelial surface antigens.
Scully PA; Steinman HK; Kennedy C; Trueblood K; Frisman DM; Voland JR
Am J Pathol; 1988 Feb; 130(2):244-51. PubMed ID: 3341448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
